期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
血栓通联合小牛血清去蛋白注射液对急性脑梗死患者血清S100B、MMP-9影响观察 被引量:13
1
作者 曹培卫 智文虹 +3 位作者 李再利 辛在娥 朱遂强 刘志广 《广西大学学报(自然科学版)》 CAS 北大核心 2020年第4期860-864,共5页
探究血栓通联合小牛血清去蛋白注射液对急性脑梗死患者血清S100B、基质金属蛋白酶-9(MMP-9)的影响。选取2016年1月至2017年12月我院神经内科收治的112例急性脑梗死患者作为研究对象,按照随机数字表法分为观察组和对照组,每组各56例。对... 探究血栓通联合小牛血清去蛋白注射液对急性脑梗死患者血清S100B、基质金属蛋白酶-9(MMP-9)的影响。选取2016年1月至2017年12月我院神经内科收治的112例急性脑梗死患者作为研究对象,按照随机数字表法分为观察组和对照组,每组各56例。对照组采用血栓通注射液治疗,观察组在对照组基础上联合小牛血清去蛋白注射液治疗。治疗2周,观察两组患者疗效,血清S100B、MMP-9变化,神经功能及安全性。观察组总有效率94.6%(53/56)明显高于对照组80.4%(45/56)(P<0.05)。治疗后,观察组血清S100B、MMP-9水平低于对照组(P<0.05);观察组NIHSS评分低于对照组,ADL评分高于对照组(P<0.05);两组患者肝肾功能比较无显著差异(P>0.05)。血栓通联合小牛血清去蛋白注射液治疗急性脑梗死患者疗效显著,可有效改善血清S100B、MMP-9水平,保护患者神经功能,安全可靠。 展开更多
关键词 血栓通 小牛血清去蛋白注射液 急性脑梗死 S100B MMP-9
下载PDF
载脂蛋白E基因多态性与脑出血血肿扩大CT预测征象相关性研究 被引量:4
2
作者 吴楚粤 朱遂强 +1 位作者 黄珊珊 叶晓东 《神经损伤与功能重建》 2021年第4期202-205,共4页
目的:分析自发性脑出血(ICH)患者的血肿扩大CT预测征象与载脂蛋白E(ApoE)基因型的相关性,以探究ApoE基因在脑出血发展过程中的可能作用。方法:纳入我科2018年6月至2020年4月符合急性ICH诊断且具有ApoE基因型检测结果的患者的临床资料和... 目的:分析自发性脑出血(ICH)患者的血肿扩大CT预测征象与载脂蛋白E(ApoE)基因型的相关性,以探究ApoE基因在脑出血发展过程中的可能作用。方法:纳入我科2018年6月至2020年4月符合急性ICH诊断且具有ApoE基因型检测结果的患者的临床资料和影像学资料。评估影像学资料,通过卡方检验及Logistic回归分析CT征象与ApoE基因的相关性。结果:发病12 h和18 h内的征象中,ApoE基因ε2携带与CT上的"黑洞征"征象有关(P=0.009,P=0.030);发病24 h内的征象中,ApoE基因ε4携带与CT上的"血肿不均质密度"征象有关(P=0.009)。Logistic回归分析结果显示,发病12及18 h内,ε2等位基因携带是CT"黑洞征"独立预测因素;发病24 h内,ε4等位基因是CT上"血肿不均质密度征"的独立预测因素。结论:ApoE不同等位基因可能参与血肿扩大,ApoE基因检测在脑出血患者诊治过程中具有重要意义。 展开更多
关键词 载脂蛋白E 基因多态性 脑出血 血肿扩大 CT征象
下载PDF
颅内未破裂动脉瘤的破裂风险和治疗策略 被引量:5
3
作者 赵建玲 朱遂强 王芙蓉 《内科急危重症杂志》 2019年第3期181-184,共4页
非创伤性蛛网膜下腔出血的患者中80%是由其颅内动脉瘤破裂引起的[1],蛛网膜下腔出血(subarachnoid hemorrhage,SAH)是脑卒中疾病中最为凶险的一种,死亡率最高可达50%[2]。防治颅内未破裂动脉瘤面临两难选择。目前所知的未破裂动脉瘤破... 非创伤性蛛网膜下腔出血的患者中80%是由其颅内动脉瘤破裂引起的[1],蛛网膜下腔出血(subarachnoid hemorrhage,SAH)是脑卒中疾病中最为凶险的一种,死亡率最高可达50%[2]。防治颅内未破裂动脉瘤面临两难选择。目前所知的未破裂动脉瘤破裂危险因素包括患者自身特点和动脉瘤特点两方面,患者特征危险因素包括高龄、女性、日本血统或芬兰血统、吸烟史、既往SAH史、高血压史等,动脉瘤特征包括大动脉瘤、动脉瘤增大、位于后循环位置、有子囊等,而不同研究可能有不同的结论[3~7]。 展开更多
关键词 颅内动脉瘤 未破裂 破裂风险 炎症 高分辨核磁共振 治疗
下载PDF
Seizures Related to Two-child Policy:A Case Report
4
作者 SONG Xiao-yan LIU Xiao-yan +3 位作者 LI Guo SUNWen zhe zhu Zhou zhu sui-qiang 《神经损伤与功能重建》 2020年第5期249-251,共3页
From 1979 to 2012,the Chinese government implemented the one-child policy to control population growth.In 2013,families in which either parent was the only one child were allowed to apply for a second child.In 2016,Ch... From 1979 to 2012,the Chinese government implemented the one-child policy to control population growth.In 2013,families in which either parent was the only one child were allowed to apply for a second child.In 2016,China’s universal two-child policy was finally imposed.As such,many children who had always been the center of their family’s universe due to the unique family structure stemming from the one-child policy era became elder siblings during their adolescence.We report a case of a 9-year-old girl who developed seizures after the birth of her younger sister.The combination of clinical observation,laboratory examinations,and video-electroencephalography was not enough to make a confident diagnosis of epilepsy initially.Given her patient history and follow-up investigation,we speculated the two-child policy was related to her seizures.To our knowledge,this is the first report of seizures strongly related to the two-child policy. 展开更多
关键词 SEIZURE two-child policy EPILEPSY psychogenic nonepileptic seizures(PNES)
下载PDF
A follow-up study on newer anti-epileptic drugs as add-on and monotherapy for partial epilepsy in China 被引量:9
5
作者 Kang Hui-cong Hu Qi +6 位作者 Liu Xiao-yan Liu Zhi-guang Zeng Zheng Liu Jian-lin Wang Min Liang Yan-ling zhu sui-qiang 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第4期646-651,共6页
Background Recently,new anti-epileptic drugs (AEDs) have been more frequently selected to treat epilepsy.In the present study,we evaluated the dynamic changes of efficacy and safety of three newer AEDs for treating ... Background Recently,new anti-epileptic drugs (AEDs) have been more frequently selected to treat epilepsy.In the present study,we evaluated the dynamic changes of efficacy and safety of three newer AEDs for treating partial epilepsy in China.Methods Patients were collected sequentially and were divided into three groups which accepted oxcarbazepine (OXC),lamotrigine (LTG) or topiramate (TPM) therapy.Each group included monotherapy and add-on therapy subgroups.We followed all patients for one year and recorded the indexes of efficacy and safety in detail.Results A total of 909 patients finished the follow-up observation.No significant difference was found in proportion of patients with 〉 or =50% reduction,〉 or =75% reduction and 100% seizure reduction in the LTG and OXC groups between the first and the second six months.In the TPM group there was a statistical difference between the first and the second six months in proportion of patients with 〉 or =50% reduction (P=-0.002),〉 or =75% reduction (P 〈0.0001) and 100% seizure reduction (P=0.009) in the monotherapy subgroup,and about 〉 or =75% reduction and 100% seizure reduction in the add-on therapy subgroup (P 〈0.0001).The efficacy between the add-on and monotherapy subgroups showed a statistical difference.The safety of the three newer AEDs was good.Conclusions The three newer AEDs all showed good efficacy and tolerability for partial epilepsy.And the efficacy can be maintained for at least one year. 展开更多
关键词 new anti-epileptic drug partial epilepsy EFFICACY SAFETY MONOTHERAPY add-on therapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部